C21005
Laufzeit: 01.01.2012 - 31.12.2013
Kurzfassung
A Phase 3, Randomized, Double-Blind, Multicenter Trial Comparing Orteronel (TAK 700) Plus Prednisone With Placebo Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer that has Progressed During or Following Docetaxel-based Therapy
Beteiligte Einrichtungen
